We aimed to address these knowledge gaps and investigate the association between ALK-positive NSCLC and VTE/ATE in a large nationwide cohort of patients with advanced lung cancer treated in tertiary and community-based centers. The gene discussed is ALK; the disease is non-small cell lung carcinoma.